ATS
IDXX icon

Ashton Thomas Securities’s Idexx Laboratories IDXX Stock Holding History

Ashton Thomas Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
637
-140
-18% -$78.5K 0.05% 246
2026
Q1 		$437K Buy
777
+1
+0.1% +$641 0.05% 260
2025
Q4 		$525K Buy
+776
New +$528K 0.1% 175
2024
Q4 		– Sell
-73
Closed -$36.9K – 697
2024
Q3 		$36.9K Buy
+73
New +$35.5K 0.01% 481

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ashton Thomas Securities's IDXX Position: Q2 2026 in Review

Ashton Thomas Securities reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $78.5K and leaving 637 shares worth $335K. The position accounts for 0.05% of the portfolio, ranked #246.

Ashton Thomas Securities first reported a position in IDXX in Q3 2024 and has held it in 4 quarters since. The position peaked at $525K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ashton Thomas Securities held 637 shares of Idexx Laboratories worth $335K as of Q2 2026.
  • Ashton Thomas Securities sold 140 Idexx Laboratories shares in Q2 2026, an estimated $78.5K.
  • Idexx Laboratories made up 0.05% of Ashton Thomas Securities's portfolio in Q2 2026, its #246 holding.
  • Ashton Thomas Securities first reported a position in Idexx Laboratories in Q3 2024 and has held it in 4 quarters since.
  • Ashton Thomas Securities's Idexx Laboratories position peaked at $525K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.